Govindan, R., Fakih, M., Price, T., Falchook, G., Desai, J., Kuo, J., … Hong, D. (2019). Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRAS(G12C) Inhibitor, in Patients with Non-Small Cell Lung Cancer. In JOURNAL OF THORACIC ONCOLOGY (Vol. 14, pp. S1125–S1126). ELSEVIER SCIENCE INC.

Govindan, R., M. Fakih, T. Price, G. Falchook, J. Desai, J. Kuo, J. Strickler, et al. “Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRAS(G12C) Inhibitor, in Patients with Non-Small Cell Lung Cancer.” In JOURNAL OF THORACIC ONCOLOGY, 14:S1125–26. ELSEVIER SCIENCE INC, 2019.

Govindan R, Fakih M, Price T, Falchook G, Desai J, Kuo J, et al. Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRAS(G12C) Inhibitor, in Patients with Non-Small Cell Lung Cancer. In: JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC; 2019. p. S1125–6.

Govindan, R., et al. “Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRAS(G12C) Inhibitor, in Patients with Non-Small Cell Lung Cancer.” JOURNAL OF THORACIC ONCOLOGY, vol. 14, no. 11, ELSEVIER SCIENCE INC, 2019, pp. S1125–26.

Govindan R, Fakih M, Price T, Falchook G, Desai J, Kuo J, Strickler J, Krauss J, Li B, Denlinger C, Durm G, Ngang J, Henary H, Ngarmchamnanrith G, Rasmussen E, Morrow PK, Hong D. Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRAS(G12C) Inhibitor, in Patients with Non-Small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC; 2019. p. S1125–S1126.